
Truveta brand logo mark in teal on a black background, featuring stacked chevron shapes forming the Truveta symbol.
Close

Research

Featured research

C-section pain management study thumbnail image in Truveta branding.

Pain management after C-section: Following the journey from hospital to home

Hospital pain medication use was consistent across groups, but prescribing varied after discharge, with some notable differences by geography.

Read More
Rising rate of non-receipt of vitamin K for newborns, January 2019–June 2026

Rising rate of non-receipt of vitamin K for newborns, 2019–June 2026

Truveta Research finds documented newborn vitamin K non-receipt rose from 5.2% in January to 8.1% in June 2026, continuing a recent upward trend.

Read More
Graphic from Truveta showing a record increase in GLP-1 prescribing among older adults following the launch of Medicare's GLP-1 Bridge program, with trend lines illustrating prescribing growth over time.

Older adults see record increase in GLP-1 prescribing following Medicare GLP-1 Bridge program

New Truveta research shows GLP-1 prescribing among adults 65+ rose 19% in July 2026, a record increase after Medicare’s GLP-1 Bridge launch.

Read More
Truveta research graphic titled '2026 Cyclosporiasis Outbreak: Diagnoses Reach Historic Levels,' featuring outbreak trend lines that illustrate a significant rise in cyclospora diagnoses during summer 2026

Cyclosporiasis diagnoses reach historic levels in 2026 summer outbreak

Real-world data reveal record cyclosporiasis diagnoses during the 2026 summer outbreak and support faster outbreak monitoring.

Read More

Featured research topics

GLP-1

Oncology

Flu/RSV

Measles

Cardiovascular